Chimera Investment Corporation  

(Public, NYSE:CIM)   Watch this stock  
Find more results for CIM
16.97
-0.29 (-1.68%)
After Hours: 17.11 +0.14 (0.82%)
Feb 21, 4:11PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 16.97 - 17.47
52 week 15.77 - 20.90
Open 17.26
Vol / Avg. 1.60M/1.45M
Mkt cap 3.19B
P/E 6.51
Div/yield 0.50/11.79
EPS 2.61
Shares 187.81M
Beta 0.67
Inst. own 52%
Apr 30, 2018
Q1 2018 Chimera Investment Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Feb 14, 2018
Q4 2017 Chimera Investment Corp Earnings Release
Feb 14, 2018
Q4 2017 Chimera Investment Corp Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin 35.71% 45.71%
Operating margin 35.68% 45.72%
EBITD margin - 43.93%
Return on average assets 2.04% 2.77%
Return on average equity 10.82% 14.54%
Employees 38 -
CDP Score - -

Address

520 Madison Ave Fl 32
NEW YORK, NY 10022-4213
United States - Map
+1-212-6262300 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Chimera Investment Corporation is a real estate investment trust (REIT). The company is engaged in the business of investing in a portfolio of mortgage assets, including agency residential mortgage-backed security (RMBS), non-agency RMBS, agency commercial mortgage-backed securities (CMBS), residential mortgage loans and real estate related securities. The Company's objective is to provide risk-adjusted returns to its investors over the long-term, primarily through dividends and secondarily through capital appreciation. The Company focuses to achieve this objective by investing in an investment portfolio of RMBS, agency CMBS, residential mortgage loans, commercial mortgage loans, real estate-related securities and various other asset classes. The MBS and real estate-related securities the Company purchases include investment-grade and non-investment grade classes, including the BB-rated, B-rated and non-rated classes. It also invests in investment grade and non-investment grade RMBS.

Officers and directors

Matthew Lambiase President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Robert S. Colligan Chief Financial Officer
Age: 46
Bio & Compensation  - Reuters
Choudhary Yarlagadda Chief Operating Officer
Age: 55
Bio & Compensation  - Reuters
Mohit Marria Chief Investment Officer
Age: 39
Bio & Compensation  - Reuters
Phillip John Kardis II Chief Legal Officer ,Secretary
Age: 55
Bio & Compensation  - Reuters
Paul Donlin Non-Executive Independent Chairman of the Board
Age: 55
Bio & Compensation  - Reuters
Mark Abrams Independent Director
Age: 68
Bio & Compensation  - Reuters
Teresa Bryce Bazemore Independent Director
Age: 57
Bio & Compensation  - Reuters
Gerard Creagh Independent Director
Age: 59
Bio & Compensation  - Reuters
Paul A. Keenan Independent Director
Age: 50
Bio & Compensation  - Reuters